Prostate cancer expressing endothelin 1 (ET-1) was shown to preferentially metastasize to the bone because ET-1 binds to the endothelin receptor A (ETA) on bone marrow stromal cells and, therefore, causes proliferation and activation of bone-forming osteoblasts. This evidence concerns the gene EDN1 and prostate cancer.